Skip to main content

Table 2 Quality assessment analysis

From: Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials

RCT

Random sequence generation

Allocation concealment

Blinding of participants and personnel

Blinding of outcome assessors

Incomplete outcome data

Selective reporting

 

Chen et al. [22]

U

U

U

U

L

L

Poor

Chullikana et al. [21]

L

L

L

L

L

L

Good

Gao et al. [15]

L

L

L

L

H

L

Fair

Gao et al. [16]

L

L

H

L

L

L

Fair

Hare et al. [23]

L

L

L

L

H

L

Fair

Lee et al. [19]

U

U

H

L

H

L

Poor

Wang et al. [17]

U

U

U

L

L

L

Poor

Kharlamov et al. [24]

U

U

U

U

L

L

Poor

Houtgraaf et al. [13]

L

L

L

L

L

L

Good

Rodrigo et al. [18]

H

U

U

U

L

L

Poor

Penn et al. [20]

U

U

L

L

L

L

Fair

Kim et al. [25]

L

U

L

L

L

L

Good

Zhang et al. [26]

L

U

L

U

L

L

Fair

  1. H: high risk, U: unclear risk, L: low risk (Cochrane Handbook For Systematic Reviews Of Intervention)